Product Images Losortan Potassium

This is a pharmaceutical label for Losartan Potassium Tablets, USP 100 mg, in two different package sizes containing either 100 or 1000 tablets. The label includes the manufacturer's name and product code (SKY-NDC 6373869810 and SKY-NDC 63739.698-10), as well as dosage information and precautions to keep the medication out of reach of children.*

Losartan Potassium Tablets, USP 25mg is a product of India, containing 100 tablets in UD form factor (10x10). The tablets are designed to contain 25g of ssan. The recommended dosage is mentioned for adults. The package should be kept out of the reach of children. The expiry date for lot number ouooooox is 20991231. The UPC barcode is 6373967310.*

This is a label of Losartan Potassium Tablets, USP 50 mg with a total of 100 tablets per bottle. The manufacturer is SKY, and the product's ID number is 63739.686-10. It is important to keep this and all drugs away from children. No other information is available.*

This is a tabular data showing the percentage of patients who achieved the primary endpoint for a comparison between two drugs, Atenolol and Losartan Potassium. The table also includes an adjusted risk reduction of 13% with a p-value of 0.021, along with time points (in months) for the study duration.*

This appears to be a chart or graph of some kind showing the percentage of patients and the effectiveness of two treatments (Atenolol and Losartan Potassium) in reducing the risk of fatal/non-fatal strokes. The adjusted risk reduction for Losartan Potassium is 25% with a significant p-value of 0.001. The data is presented over a period of 66 months. No additional information is available.*

This appears to be a portion of a table or chart displaying information about the effectiveness of Losartan Potassium tablets compared to a placebo in reducing the risk of an event (not specified what type of event). The table shows the percentage of patients with the event in the Losartan group (0) and in the placebo group (20). It also states that the risk reduction with Losartan was 16.1% and the statistical significance with a p-value of 0.022. The meaning and context of the "2 2 E 48" at the bottom is not clear.*